Kennedy Capital Management, Inc. Blueprint Medicines Corp Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 3,816 shares of BPMC stock, worth $423,881. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,816
Previous 3,269
16.73%
Holding current value
$423,881
Previous $352,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$742 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$738 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$598 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$440 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$307 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.63B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...